Meta-Analysis
Copyright ©The Author(s) 2022.
World J Clin Cases. Jun 26, 2022; 10(18): 6091-6104
Published online Jun 26, 2022. doi: 10.12998/wjcc.v10.i18.6091
Table 3 GRADE evidence profile
Quality assessment-No. of studiesQuality assessment-study designQuality assessment-risk of biasQuality assessment-inconsistencyQuality assessment-indirectnessQuality assessment-imprecisionQuality assessment-Publication biasSummary of findings-number of patient, with IFXSummary of findings-number of patient, with ADASummary of findings-effect, relative (95%CI)Summary of findings-effect, absolute (95%CI)Summary of findings-effect, Quality
Induction of response
5Observational studyNot seriousNot seriousNot seriousNot seriousNot found403/525417/515OR: 1.27 (0.93-1.74)768 per 1000⨁⨁◯◯
Induction of remission
4Observational studyNot seriousNot seriousNot seriousNot seriousNot found368/494244/318OR: 1.11 (0.78-1.57)745 per 1000⨁⨁◯◯
Maintenance of response
7Observational studyNot seriousNot seriousNot seriousNot seriousNot found611/896639/932OR: 1.02 (0.83-1.25)682 per 1000⨁⨁◯◯
Maintenance of remission
6Observational studyNot seriousNot seriousNot seriousNot seriousNot found255/442219/328OR: 1.26 (0.87-1.82)577 per 1000⨁⨁◯◯
Secondary loss of response
6Observational studyNot seriousNot seriousNot seriousNot seriousNot found191/704172/603OR: 1.01 (0.65-1.55)271 per 1000⨁⨁◯◯
Overall adverse events
8Observational studyNot seriousNot seriousNot seriousNot seriousNot found364/900205/753OR: 0.62 (0.42-0.91)404 per 1000⨁⨁◯◯
Severe adverse events
7Observational studyNot seriousNot seriousNot seriousNot seriousNot found139/85980/688OR: 0.75 (0.32-1.72)162 per 1000⨁⨁◯◯
Opportunistic infection
6Observational studyNot seriousNot seriousNot seriousNot seriousNot found144/98885/922OR: 0.96 (0.66-1.40)146 per 1000⨁⨁◯◯